YKL-40 as a novel diagnostic biomarker in Toxoplasmosis.

Farah Abd Al-Zahra Shahad, Ahmed A Mohammed, Ghaith Ali Jasim
{"title":"YKL-40 as a novel diagnostic biomarker in Toxoplasmosis.","authors":"Farah Abd Al-Zahra Shahad,&nbsp;Ahmed A Mohammed,&nbsp;Ghaith Ali Jasim","doi":"10.47750/jptcp.2022.932","DOIUrl":null,"url":null,"abstract":"<p><p>Toxoplasmosis is one of the most globally prevalent zoonotic infection caused by an obligate, intracellular parasite called <i>Toxoplasma gondii</i>. Toxoplasmosis actively triggers an acute immune response and inflammatory reactions, which causes serious pathological changes in various tissues in the human body, and more evidently localizes in different nervous tissues of various body organs. The YKL-40 is a glycoprotein secreted by numerous cell types in different patterns associated with various pathological processes such as inflammatory reactions, tissue remodeling, and fibrosis, and is a disease-specific biomarker of neuroinflammation. Therefore, this study aimed to determine whether the YKL-40 is markedly increased in toxoplasmosis or not and whether its level is different between the acute and chronic phases of the infection to determine if it can be used as a clinically useful biomarker in the diagnosis, and determination of disease severity and follow-up of toxoplasmosis. Accordingly, a total of 80 serum samples were collected from previously diagnosed female patients of different ages with toxoplasmosis. In addition, serum samples of 10 healthy females were used as the control. Patients were first divided into two groups (30 patients with acute infection, and 50 patients with chronic infection) depending on the results of detection of specific anti-<i>Toxoplasma</i> IgM and IgG by enzyme-linked immunosorbent assay (ELISA). The level of YKL-40 was then measured in the patients' serum by ELISA. The statistical analysis of data clearly disclosed very highly significant differences (P < 0.001) between the level of YKL-40 in the acute infection group and healthy controls, chronic infection group and healthy controls, and between the groups with acute and chronic infections. These findings led to conclude that YKL-40 classify as a unique and sophisticated biomarker in the diagnosis of toxoplasmosis where it can vitally be used to detect the stage of the disease, whether acute or chronic, besides its ability to detect the infection.</p>","PeriodicalId":73904,"journal":{"name":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","volume":"29 2","pages":"e61-e70"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47750/jptcp.2022.932","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Toxoplasmosis is one of the most globally prevalent zoonotic infection caused by an obligate, intracellular parasite called Toxoplasma gondii. Toxoplasmosis actively triggers an acute immune response and inflammatory reactions, which causes serious pathological changes in various tissues in the human body, and more evidently localizes in different nervous tissues of various body organs. The YKL-40 is a glycoprotein secreted by numerous cell types in different patterns associated with various pathological processes such as inflammatory reactions, tissue remodeling, and fibrosis, and is a disease-specific biomarker of neuroinflammation. Therefore, this study aimed to determine whether the YKL-40 is markedly increased in toxoplasmosis or not and whether its level is different between the acute and chronic phases of the infection to determine if it can be used as a clinically useful biomarker in the diagnosis, and determination of disease severity and follow-up of toxoplasmosis. Accordingly, a total of 80 serum samples were collected from previously diagnosed female patients of different ages with toxoplasmosis. In addition, serum samples of 10 healthy females were used as the control. Patients were first divided into two groups (30 patients with acute infection, and 50 patients with chronic infection) depending on the results of detection of specific anti-Toxoplasma IgM and IgG by enzyme-linked immunosorbent assay (ELISA). The level of YKL-40 was then measured in the patients' serum by ELISA. The statistical analysis of data clearly disclosed very highly significant differences (P < 0.001) between the level of YKL-40 in the acute infection group and healthy controls, chronic infection group and healthy controls, and between the groups with acute and chronic infections. These findings led to conclude that YKL-40 classify as a unique and sophisticated biomarker in the diagnosis of toxoplasmosis where it can vitally be used to detect the stage of the disease, whether acute or chronic, besides its ability to detect the infection.

YKL-40作为弓形虫病新的诊断生物标志物。
弓形虫病是全球最普遍的人畜共患感染之一,由专性细胞内寄生虫刚地弓形虫引起。弓形虫病主动引发急性免疫反应和炎症反应,引起人体各组织的严重病理改变,更明显地局限于身体各器官的不同神经组织。YKL-40是一种由多种细胞以不同模式分泌的糖蛋白,与各种病理过程(如炎症反应、组织重塑和纤维化)相关,是神经炎症的疾病特异性生物标志物。因此,本研究旨在确定YKL-40在弓形虫病中是否明显升高,以及在感染的急性期和慢性期是否存在差异,以确定其是否可以作为临床上有用的生物标志物,用于弓形虫病的诊断、疾病严重程度的判断和随访。因此,我们收集了80份不同年龄女性弓形虫病患者的血清样本。另外,以10名健康女性的血清样本作为对照。首先根据酶联免疫吸附试验(ELISA)检测特异性抗弓形虫IgM和IgG的结果,将患者分为急性感染组30例和慢性感染组50例。ELISA法检测患者血清中YKL-40水平。经统计分析,YKL-40在急性感染组与健康对照组、慢性感染组与健康对照组、急性感染组与慢性感染组之间存在极显著差异(P < 0.001)。这些发现使我们得出结论,YKL-40在弓形虫病诊断中是一种独特而复杂的生物标志物,除了检测感染的能力外,它还可以重要地用于检测疾病的阶段,无论是急性还是慢性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信